SEC Form 4 research
| Issuer | Iambic Therapeutics, Inc. |
|---|---|
| Tickers | IAM |
| Reporting owners | 17 |
| Officers and directors | 1 |
| Last public filing | 2026-10-19 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-19 | 2026-10-16 | Rachlin Evan Lockwood | P | 718,750 | $16 | Not reported |
| 2026-10-16 | 2026-10-14 | EMSTER KURT VON | A | 20,300 | $0 | Not reported |
| 2026-10-16 | 2026-10-14 | Vogelstein R Jacob | A | 20,300 | $0 | Not reported |
| 2026-10-16 | 2026-10-14 | TAGLIAFERRI MARY | A | 20,300 | $0 | Not reported |
| 2026-10-16 | 2026-10-14 | Sharp Shalini | A | 20,300 | $0 | Not reported |
| 2026-10-16 | 2026-10-14 | RASTETTER WILLIAM H | A | 40,600 | $0 | Not reported |
| 2026-10-16 | 2026-10-14 | Rachlin Evan Lockwood | A | 20,300 | $0 | Not reported |
| 2026-10-16 | 2026-10-14 | Secora Michael | A | 28,400 | $0 | Not reported |
| 2026-10-16 | 2026-10-14 | Secora Michael | A | 170,300 | $0 | Not reported |
| 2026-10-16 | 2026-10-14 | Olson Peter A | A | 19,500 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.